Sandbox leucocytosis: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 315: | Line 315: | ||
|[[Diffuse large B-cell lymphoma]] | |[[Diffuse large B-cell lymphoma]] | ||
| | | | ||
*Germinal centre B-cell-like (GCB) | |||
*Activated B-cell-like (ABC).<ref name="Shipp2002">{{cite journal |doi=10.1038/nm0102-68 |pmid=11786909 |title=Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning |journal=Nature Medicine |volume=8 |issue=1 |pages=68–74 |year=2002 |last1=Shipp |first1=Margaret A. |last2=Ross |first2=Ken N. |last3=Tamayo |first3=Pablo |last4=Weng |first4=Andrew P. |last5=Kutok |first5=Jeffery L. |last6=Aguiar |first6=Ricardo C.T. |last7=Gaasenbeek |first7=Michelle |last8=Angelo |first8=Michael |last9=Reich |first9=Michael |last10=Pinkus |first10=Geraldine S. |last11=Ray |first11=Tane S. |last12=Koval |first12=Margaret A. |last13=Last |first13=Kim W. |last14=Norton |first14=Andrew |last15=Lister |first15=T. Andrew |last16=Mesirov |first16=Jill |last17=Neuberg |first17=Donna S. |last18=Lander |first18=Eric S. |last19=Aster |first19=Jon C. |last20=Golub |first20=Todd R. }}</ref><ref name="Rosenwald2002">{{cite journal |doi=10.1056/NEJMoa012914 |pmid=12075054 |title=The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma |journal=New England Journal of Medicine |volume=346 |issue=25 |pages=1937–47 |year=2002 |last1=Rosenwald |first1=Andreas |last2=Wright |first2=George |last3=Chan |first3=Wing C. |last4=Connors |first4=Joseph M. |last5=Campo |first5=Elias |last6=Fisher |first6=Richard I. |last7=Gascoyne |first7=Randy D. |last8=Muller-Hermelink |first8=H. Konrad |last9=Smeland |first9=Erlend B. |last10=Giltnane |first10=Jena M. |last11=Hurt |first11=Elaine M. |last12=Zhao |first12=Hong |last13=Averett |first13=Lauren |last14=Yang |first14=Liming |last15=Wilson |first15=Wyndham H. |last16=Jaffe |first16=Elaine S. |last17=Simon |first17=Richard |last18=Klausner |first18=Richard D. |last19=Powell |first19=John |last20=Duffey |first20=Patricia L. |last21=Longo |first21=Dan L. |last22=Greiner |first22=Timothy C. |last23=Weisenburger |first23=Dennis D. |last24=Sanger |first24=Warren G. |last25=Dave |first25=Bhavana J. |last26=Lynch |first26=James C. |last27=Vose |first27=Julie |last28=Armitage |first28=James O. |last29=Montserrat |first29=Emilio |last30=López-Guillermo |first30=Armando |display-authors=29 }}</ref><ref name="Wright2003">{{cite journal |doi=10.1073/pnas.1732008100 |pmid=12900505 |pmc=187912 |jstor=3147650 |title=A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma |journal=Proceedings of the National Academy of Sciences |volume=100 |issue=17 |pages=9991–6 |year=2003 |last1=Wright |first1=G. |last2=Tan |first2=B. |last3=Rosenwald |first3=A. |last4=Hurt |first4=E. H. |last5=Wiestner |first5=A. |last6=Staudt |first6=L. M. |bibcode=2003PNAS..100.9991W }}</ref> | |||
**B cell receptor (BCR) signalling | |||
**B cell migration/adhesion | |||
**Cell-cell interactions in immune niches | |||
**Production and class-switching of immunoglobulins<ref name="pmid25541152">{{cite journal |doi=10.1038/leu.2014.351 |title=MicroRNAs in B-cell lymphomas: How a complex biology gets more complex |journal=Leukemia |year=2015 |last1=Musilova |first1=K |last2=Mraz |first2=M }}</ref> | |||
| | | | ||
| | | | ||
Line 321: | Line 327: | ||
| | | | ||
| | | | ||
====Centroblastic==== | |||
*Medium-to-large-sized [[Lymphocyte|lymphocytes]] | |||
*Monomorphic | |||
====Immunoblastic::==== | |||
*> 90% immunoblasts | |||
*Trapezoid shaped large lymphoid cells with significant [[basophilic]] cytoplasm | |||
====Anaplastic:==== | |||
*Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells of Hodgkin's lymphoma or Anaplastic Large cell Lymphoma. | |||
|- | |- | ||
|[[Burkitt lymphoma]] | |[[Burkitt lymphoma]] |
Revision as of 02:29, 20 August 2018
- Leukocytosis is defined as an elevated white blood cell (WBC) count greater than 11,000 per mm3 (11.0 × 109 per L).
- The most common type of leukocytosis is neutrophilia.
- Neutrophilia can be defined as an increase in the absolute number of mature neutrophils to greater than 7,000 per mm3 [7.0 × 109 per L].
Differentiating Symptoms | Differentiating physical exam findings | Differentiating Labs | |||
---|---|---|---|---|---|
Physiological variation | Birth | ||||
Adult | |||||
Pregnancy | |||||
Primary | Congenital | Heridatary neutrophilia | |||
Chronic idiopathic neutrophilia | |||||
Down syndrome | |||||
LAD | |||||
Acquired | CML | ||||
Polycythemia Vera | |||||
Secondary | Infection | Acute | |||
Chronic | |||||
Connective tissue disorders | RA | ||||
JRA | |||||
IBD | |||||
Chronic hepatitis | |||||
Drug induced | Steriod | ||||
Lithium | |||||
Beta agonists | |||||
Cytokines | |||||
Marrow stimulation | Hemolytic anemia | ||||
Immature thrombocytopenia | |||||
Post splenectomy | |||||
Metabolic | Diabetic coma | ||||
Acidosis | |||||
Thyroid strom | |||||
Acute Gout | |||||
Seizures |
Pathophysiology | Symptoms | History | Physical Examination | Laboratory Findings | ||||
---|---|---|---|---|---|---|---|---|
Immunochemistry | Blood work | Biospy | ||||||
B cell lymphoma | Mantle cell lymphoma |
|
|
|
|
|
CBC
|
|
Nodal marginal zone B-cell lymphoma |
|
|
|
|
| |||
Splenic marginal zone lymphoma |
|
| ||||||
Hairy cell leukemia |
|
|
|
| ||||
Plasma cell myeloma | ||||||||
Diffuse large B-cell lymphoma |
Centroblastic
Immunoblastic::
Anaplastic:
| |||||||
Burkitt lymphoma |
|
|
|
| ||||
T cell lymphoma | T-cell granular lymphocytic leukemia | |||||||
Mycosis fungoides / Sézary syndrome | ||||||||
Peripheral T-cell lymphoma, | ||||||||
Subcutaneous panniculitis-like T-cell lymphoma | ||||||||
Enteropathy-type intestinal T-cell lymphoma | ||||||||
Anaplastic large cell lymphoma | ||||||||
Aggressive NK-cell leukemia |
Differential diagnosis of Lymphocytosis
Pathophyisiology | Symptoms | History | Physical Examination | Laboratory Findings | |
---|---|---|---|---|---|
AML |
|
|
|
|
|
ALL |
|
|
|
|
|
CML |
|
|
|
| |
CLL |
|
|
|
|
|
Pathophysiology | Symptoms | History | Physical Examination | Laboratory Findings | ||||
---|---|---|---|---|---|---|---|---|
CBC | Blood smear | Immunophenotype | ||||||
Monoclonal B lymphocytosis |
|
|
|
|
|
|
|
|
Congenital B cell lymphocytosis |
|
|||||||
Large granular lymphocyte leukemia |
|
|
|
|
||||
Chronic lymphocytic leukemia | ||||||||
Sezary syndrome | ||||||||
Mantle cell lymphoma | ||||||||
Follicular lymphoma | ||||||||
Splenic marginal zone lymphoma | ||||||||
Acute lymphoblastic leukemia | ||||||||
Acute Promyelocytic Leukemia | ||||||||
Diffuse Large Cell Lymphoma |
|
|
|
Differential for Eosinophilia
Pathophysiology | Symptoms | History | Physical Examination | Laboratory Findings | |
---|---|---|---|---|---|
Parasitic Infections |
|
Vary depending on the organism
|
|
|
|
Allergy/ Atopic Diseases |
|
Systemic anaphylaxis
Local anaphylaxis (atopy)
|
|
|
|
Hypereosinophilic syndromes (HES) |
|
|
| ||
Acute myelogenous leukemias |
|
|
|
|
|
Hodgkin's, T- and B-cell lymphomas) |
|
|
|
|
|
Churg-Strauss
(Eosinophilic granulomatosis with polyangiitis) |
|
|
|
|
|
Systemic mastocytosis |
|
|
History of/ Associated with
|
|
|
- ↑ Shipp, Margaret A.; Ross, Ken N.; Tamayo, Pablo; Weng, Andrew P.; Kutok, Jeffery L.; Aguiar, Ricardo C.T.; Gaasenbeek, Michelle; Angelo, Michael; Reich, Michael; Pinkus, Geraldine S.; Ray, Tane S.; Koval, Margaret A.; Last, Kim W.; Norton, Andrew; Lister, T. Andrew; Mesirov, Jill; Neuberg, Donna S.; Lander, Eric S.; Aster, Jon C.; Golub, Todd R. (2002). "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning". Nature Medicine. 8 (1): 68–74. doi:10.1038/nm0102-68. PMID 11786909.
- ↑ Rosenwald, Andreas; Wright, George; Chan, Wing C.; Connors, Joseph M.; Campo, Elias; Fisher, Richard I.; Gascoyne, Randy D.; Muller-Hermelink, H. Konrad; Smeland, Erlend B.; Giltnane, Jena M.; Hurt, Elaine M.; Zhao, Hong; Averett, Lauren; Yang, Liming; Wilson, Wyndham H.; Jaffe, Elaine S.; Simon, Richard; Klausner, Richard D.; Powell, John; Duffey, Patricia L.; Longo, Dan L.; Greiner, Timothy C.; Weisenburger, Dennis D.; Sanger, Warren G.; Dave, Bhavana J.; Lynch, James C.; Vose, Julie; Armitage, James O.; Montserrat, Emilio; et al. (2002). "The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma". New England Journal of Medicine. 346 (25): 1937–47. doi:10.1056/NEJMoa012914. PMID 12075054.
- ↑ Wright, G.; Tan, B.; Rosenwald, A.; Hurt, E. H.; Wiestner, A.; Staudt, L. M. (2003). "A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma". Proceedings of the National Academy of Sciences. 100 (17): 9991–6. Bibcode:2003PNAS..100.9991W. doi:10.1073/pnas.1732008100. JSTOR 3147650. PMC 187912. PMID 12900505.
- ↑ Musilova, K; Mraz, M (2015). "MicroRNAs in B-cell lymphomas: How a complex biology gets more complex". Leukemia. doi:10.1038/leu.2014.351.